Related Experiment Video

Updated: Feb 10, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K

Diagnostic accuracy of natriuretic peptides for acute heart failure: a review

S-L Zhou1, J Zhang, T-T Song

  • 1Departments of Emergency, Yidu Central Hospital of Weifang, Weifang, Shandong Province, China. wang_huaixin1@163.com.

European Review for Medical and Pharmacological Sciences
|May 16, 2018
PubMed

Insights

Accurate diagnosis of acute heart failure is crucial. This review highlights natriuretic peptides, like BNP and NT-proBNP, as valuable biochemical markers for rapid and reliable emergency department diagnosis.

Area of Science:

  • Cardiology
  • Biochemistry
  • Emergency Medicine

Background:

  • Heart failure incidence and costs are rising, necessitating accurate and timely diagnosis.
  • Current diagnostic methods in emergency departments are challenging, with only 40-50% accuracy for heart failure.
  • There is a need for more precise diagnostic tests based on biochemical factors over general symptoms.

Purpose of the Study:

  • To review the role and diagnostic value of individual natriuretic peptides.
  • To focus on Brain Natriuretic Peptide (BNP), N-terminal pro-BNP (NT-proBNP), and Mid-regional pro-atrial natriuretic peptide (MR-proANP).
  • To assess their utility in diagnosing acute heart failure.

Main Methods:

  • Review of existing literature on natriuretic peptides in heart failure diagnosis.
  • Analysis of biochemical properties and clinical application of BNP, NT-proBNP, and MR-proANP.
  • Evaluation of their effectiveness in emergency department settings.

Main Results:

  • Natriuretic peptides are cost-effective, easy to use, and aid in excluding heart failure as a cause of dyspnea.
  • BNP, NT-proBNP, and MR-proANP show significant value in diagnosing acute heart failure.
  • These biomarkers offer improved accuracy compared to symptom-based assessments.

Conclusions:

  • Natriuretic peptides are essential tools for the accurate diagnosis of acute heart failure.
  • Their use in emergency departments improves diagnostic confidence and patient management.
  • Further integration of these biochemical markers is recommended for routine heart failure assessment.

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
425
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
993
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.9K